financetom
Business
financetom
/
Business
/
Factbox-What has UnitedHealth restored and what is next after major hack?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Factbox-What has UnitedHealth restored and what is next after major hack?
Mar 14, 2024 11:14 AM

(Reuters) -UnitedHealth Group has brought back online the pharmacy systems at its Change Healthcare technology unit following the Feb. 21 ransomware hack that disrupted the U.S. healthcare system.

The healthcare conglomerate expects the payment platform to be functional and begin restoring the medical claims network starting mid-March. UnitedHealth is likely to need several months to make a full recovery, according to security experts.

The following are some of its largest businesses and UnitedHealth's plans for how and when to fix them:

PRESCRIPTION DRUG PROCESSING

Change Healthcare acts as a financial clearing house connecting the companies that managed drug benefits called pharmacy benefit managers with pharmacies. Without that technology, pharmacies cannot verify if a patient is covered by a healthcare plan for a particular drug and how much that patient was expected to pay out of pocket.

As of March 13, all major pharmacy and payment systems are up and more than 99% of pre-incident claim volume is flowing, UnitedHealth said.

There are still pharmacies that remained offline and there is disruption for infusion pharmacies and interruptions for some Medicaid fee-for-service customers, the company has said.   

PRESCRIPTION DRUG COUPONS

UnitedHealth's tech unit processes discounts that manufacturers offer on some of their drugs through electronic coupons. Pharmacies could not apply many of these coupons when Change's systems went down, leaving patients to pay full price for the drugs upfront. Some manufacturers, including Eli Lilly, offered to reimburse patients for the amount their coupons would have covered.

UnitedHealth says its pharmacy network reconnection allows the majority of coupons it manages to again be processed. Coupons handled by rival McKesson's RelayHealth have not been disrupted.

INSURANCE CLAIMS

Healthcare providers including hospitals submit health insurance claims to Change, which sends them to health insurance companies to evaluate and process. After the cyberattack, these providers lost a primary means of processing payments for their services through patients' healthcare plans.

Beginning the week of March 18, UnitedHealth will begin bringing up the claims system for reconnection and testing in a phased manner. It recommends that customers use a workaround by reconnecting through an alternate network in the interim.

It said full service will be restored once testing has been completed.

The company said some providers may need more restoration work before they can submit claims and that there are some who have not been able to implement workaround solutions.

(Reporting by Patrick Wingrove in New York and Sriparna Roy in Bengaluru; Editing by Bill Berkrot and Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mobility tech firm ECARX turns profitable on higher shipment volumes in Q3 
Mobility tech firm ECARX turns profitable on higher shipment volumes in Q3 
Nov 3, 2025
Overview * ECARX ( ECX ) Q3 revenue grows 11% YoY to $219.9 mln, driven by higher shipment volumes * Company achieves first net profit of $0.9 mln, compared to a loss last year * Adjusted EBITDA reaches $8.3 mln, reflecting improved operational efficiency Outlook * ECARX ( ECX ) expects to maintain growth momentum into next quarter and beyond...
TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast
TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast
Nov 3, 2025
Overview * TG Therapeutics Q3 2025 revenue was $161.7 mln, driven by BRIUMVI sales * Company raises 2025 global revenue target to $600 mln, BRIUMVI U.S. target to $585 mln * Completed $100 mln share repurchase, authorized additional $100 mln program Outlook * TG Therapeutics ( TGTX ) raises 2025 global revenue target to $600 mln * Company increases 2025...
Karyopharm Therapeutics' Q3 net loss widens
Karyopharm Therapeutics' Q3 net loss widens
Nov 3, 2025
Overview * Karyopharm Q3 total revenue rises to $44 mln, driven by XPOVIO sales growth * Net loss for Q3 2025 was $33.1 mln, slightly higher than last year * Company reaffirms full-year 2025 revenue guidance of $140 mln to $155 mln Outlook * Karyopharm reaffirms 2025 total revenue guidance of $140 mln to $155 mln * Company expects 2025...
BioCryst Pharma Q3 operating profit up, raises FY ORLADEYO sales guidance 
BioCryst Pharma Q3 operating profit up, raises FY ORLADEYO sales guidance 
Nov 3, 2025
Overview * BioCryst Q3 operating profit increased 285% y-o-y, reflecting strong leverage * ORLADEYO Q3 revenue up 37% y-o-y, driven by strong patient demand * Company raises FY 2025 ORLADEYO revenue guidance Outlook * BioCryst raises FY 2025 ORLADEYO revenue guidance to $590-$600 mln * Company lowers FY 2025 non-GAAP operating expenses to $430-$440 mln * Company expects positive cash...
Copyright 2023-2026 - www.financetom.com All Rights Reserved